Listening, Engaging and Learning: Lilly Social Media 1

laptop and stethoscope by jfcherry (CC by SA)

laptop and stethoscope by jfcherry (CC by SA)

Earlier this year, we reached our 2nd anniversary on Twitter. When we first started out, we weren’t quite sure what to expect. We began with a foundational belief  “that drug development processes must improve, and that open innovation methods can be used to foster necessary changes.”

In order to have the conversations that would lead us down the path to developing more patient-friendly tools and resources for clinical trials, we figured that social media would be a good place to start. In the time since our first tweet, we’ve come to know people with a wide range of of experiences, perspectives and ideas when it comes to drug development. And, these ideas have had a significant impact on what we’re doing at Lilly COI today.

Our involvement in the online community is one of Lilly’s social media channels, which span a wide variety of platforms including blogs, Twitter, Facebook, Pinterest, Instagram and YouTube. Each has a different focus, but there is common high level intent—engage in public on important issues surrounding disease management and prevention, currently available medicines, and innovation towards the much-needed new medicines of tomorrow.

Here’s a brief overview of each of the channels within Lilly’s online network:



LillyPad focuses on public policy issues, corporate responsibility initiatives, advocacy efforts and the work Lilly employees do every day to make the world a healthier place to live. They share their perspective on issues that affect people everywhere, from health and wellness to innovation and job creation. Follow them to learn more about the debates on health care and innovation globally. You can find LillyPad on their blog, Twitter account and Facebook page.

Campaign for Modern Medicines

Lilly Campaign for Modern Medicines

The Campaign for Modern Medicines champions the public policies necessary to ensure individuals have access to the safe, effective, and breakthrough medicines of today and tomorrow. The campaign is made up of a  diverse coalition of individuals and organizations who believe that a robust, united and vibrant community of empowered advocates can have a real impact on the policy decisions that will improve our health. You can find the Campaign for Modern Medicines on their blog, Twitter, Facebook, and YouTube.

PACE Network

Lilly Pace Network USACreated by Lilly Oncology as a global collaboration spanning diverse sectors, PACE stands for Patient Access to Cancer care Excellence. PACE encourages public policies and health care decisions that speed the development of new medicines, assure cancer treatments respond to the needs and qualities of individual patients, and improve patient access to the most effective cancer medicines. They believe that progress against cancer is by nature stepwise, but with the insights and tools of today’s science it does not need to be slow. You can find PACE on Twitter, Facebook and

Lilly Oncology on Canvas

Lilly Oncology on CanvasOncology On CanvasSM celebrates its 10-year anniversary with it’s sixth competition. The competition is presented by Lilly Oncology and the National Coalition for Cancer Survivorship (NCCS), and invites residents of the U.S. and Puerto Rico who have been touched by cancer to express through art and narrative, the life-affirming changes that give their cancer journeys meaning. To date, more than 4,100 individuals have participated. You can find updates on the competition through their Twitter, Facebook, YouTube and Pinterest accounts.

Eli Lilly and Company

Eli Lilly and CompanyThe Lilly corporate social media pages share engaging content reflective of Lilly’s culture, focus on global corporate responsibility and emphasis on promoting diversity both at Lilly and in the communities in which it operates. You can find them on FacebookTwitterYouTube, and most recently, Instagram.


Elanco, Enough, #Feedthe9, Sensible TableElanco is a division of Eli Lilly and Company that focuses on global animal health. But ultimately, people also benefit from Elanco’s work. Improving the health and efficiency of animals helps to ensure a sufficient supply of safe, affordable food for today and in the future. It also contributes to the company’s commitment to fight hunger worldwide. You can learn about Elanco at their home page, support hunger-fighting efforts by visiting, and follow @Elanco and the hashtag  #FeedThe9 on Twitter. You can also follow Elanco’s president, Jeff Simmons, at @JeffSimmons2050.

Lilly Health

Lilly Health@LillyHealth is a Twitter account run by Lilly’s therapeutic communications team. Its focus is on providing health news and information on a variety of conditions.

Continuous Engagement = Continuous Learning

Lilly’s first foray into social media started a little over three years ago, with LillyPad’s first blog and Twitter account. Though three years can seem like a long time in terms of internet culture, it’s really just the beginning–we and the pharma industry as a whole still have a lot to learn about how to engage with patients and consumers online. Our hope is that as we continue to get to know more and more members of the patient and scientific communities, that we can keep the lines of communication open and transparent and keep learning from each other. In order to improve drug development, we need every one to come to the table with their stories and their best ideas, so that we can break down barriers to clinical trial participation, and get life-saving and life-altering treatments to everyone faster.

No matter what your main area of interest is—public policy, clinical research, disease prevention, media relations or patient engagement—we hope you’ll continue to share and engage with us. Let us know how we’re doing at Lilly COI in the comments below or on Twitter.

One comment

  1. So glad to have met you all, and so thankful for all you are doing to change the face of clinical trials. While change does take time, you guys “get” and understand that the “same old, same old” doesn’t work for many diseases…especially ALS. Thanks for opening the conversation and moving forward to take clinical trials to a much needed new level.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s